Differences in blood activation related to roller/centrifugal pumps and heparin coated/uncoated surfaces in a cardiopulmonary bypass model circuit
- 1 March 1996
- journal article
- Published by SAGE Publications in Perfusion
- Vol. 11 (2) , 113-123
- https://doi.org/10.1177/026765919601100205
Abstract
An in vitro model cardiopulmonary bypass (CPB) circuit consisting ot tubing, oxygenator and venous reservoirs with either a roller or a centrifugal pump, and with either heparin-coated (Carmeda Bioactive Surface, CBAS) or uncoated surfaces, was studied with respect to 'blood activation', using small- scale-based blood volume (450 + 500 ml). Sixteen circuits were tested in each pump group, eight with and eight without heparin-coated surfaces, by circulating heparinized fresh human blood for 72 hours at 30°C. Blood plasma, sampled at defined intervals, was analysed for haemolysis (lactate dehydrogenase and potassium), complement activation (C3bc and C5b-9 (TCC)), complement lytic inhibitors (vitronectin and clusterin), coagulation activation (fibrinopeptide A), granulocyte (lactoferrin and myeloperoxidase) and platelet (β-thromboglobulin) activation and contaminating endotoxin. The heparin coating significantly reduced the concentrations of C3bc, TCC, fibrinopeptide A, lactoferrin, myeloperoxidase and β-thromboglobulin. The two pump types did not differ with respect to these parameters, but the roller pump caused significantly higher increases in plasma LDH and potassium and significantly greater reductions in clusterin and vitronectin than the centrifugal pump. Endotoxin concentration was low at the start and after 24 hours in all groups. These results confirm that heparin-coated CPB surfaces reduce blood activation, and suggest that centrifugal pumps cause less haemolysis and less reduction in lytic complement inhibitors than roller pumps.Keywords
This publication has 31 references indexed in Scilit:
- Roller and centrifugal pumps compared in vitro with regard to haemolysis, granulocyte and complement activationPerfusion, 1994
- Evidence for iC3 generation during cardiopulmonary bypass as the result of blood-gas interactionClinical and Experimental Immunology, 1993
- In‐Vitro Assessment of Centrifugal Pumps for Ventricular AssistArtificial Organs, 1990
- Platelet and neutrophil activation in cardiopulmonary bypassThe Annals of Thoracic Surgery, 1990
- SP-40,40 is an inhibitor of C5b-6-initiated haemolysisInternational Immunology, 1989
- Deposition of Terminal C5b–9 Complement Complexes on Erythrocytes and Leukocytes during Cardiopulmonary BypassNew England Journal of Medicine, 1988
- Effects of Protamine Administration after Cardiopulmonary Bypass on Complement, Blood Elements, and the Hemodynamic StateThe Annals of Thoracic Surgery, 1986
- Hemostasis Changes During Cardiopulmonary Bypass SurgerySeminars in Thrombosis and Hemostasis, 1985
- Elevated plasma fibrinopeptide A and thromboxane B2 levels during cardiopulmonary bypass.Circulation, 1980
- Serum Myeloperoxidase and Lactoferrin in NeutropeniaScandinavian Journal of Haematology, 1977